Navigation Links
Spherix Regains Compliance With NASDAQ Listing Rule
Date:5/24/2011

BETHESDA, Md., May 24, 2011 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEXD) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies – today announced that it has regained compliance with NASDAQ listing rule 5550(a)(2), which concerns minimum bid price listing requirements.

As previously announced, Spherix was notified by NASDAQ that its common stock failed to meet the minimum bid price; thus the Company was put on notice of a potential de-listing of its stock if it failed to regain compliance with the rule.  On May 24, 2011, NASDAQ provided confirmation to the Company that the closing bid price for the prior 10 business days had met the minimum bid price requirement; thus the Company has regained compliance and the de-listing matter with NASDAQ has been closed.

About Spherix

Spherix Incorporated was launched in 1967 as a scientific research company under the name Biospherics Research.  The Company now leverages its scientific and technical expertise and experience through its two subsidiaries – Biospherics Incorporated and Spherix Consulting, Inc.  Biospherics is dedicated to development of D-tagatose and recently completed a Phase 3 clinical trial to study the use of D-tagatose as a treatment for Type 2 diabetes.  Biospherics is actively seeking a pharma partner to continue the diabetes development while exploring D-tagatose as a potential treatment for high triglycerides, a risk factor for atherosclerosis, myocardial infarction, and stroke. Spherix's Consulting subsidiary provides scientific and strategic support for suppliers, manufacturers, distributors and retailers of conventional foods, biotechnology-derived foods, medical foods, infant formulas, food ingredients, dietary supplements, food contact substances, phar
'/>"/>

SOURCE Spherix Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Spherix Announces First Quarter Financial Results
2. Spherix Announces Reverse Stock Split Effective May 6, 2011
3. Spherix to Effect Reverse Stock Split
4. Spherix Announces 2010 Financial Results
5. Spherix to Present at the BIO-Windhover/Pharmaceutical Strategic Outlook 2011 Conference
6. Spherix to Present at the 13th Annual BIO CEO & Investor Conference
7. Spherix Announces Closing of Registered Direct Offering of $2.77 Million in Common Stock and Warrants
8. Spherix to Present at Two Upcoming Prominent Finance Conferences
9. Spherix Phase 2 Trial with D-tagatose Determines Minimum Dose for HbA1c and Triglycerides
10. Spherix Signs Research Contract With a Leading Global Contract Research Organization to Investigate Role of D-tagatose in Lowering Triglycerides
11. Spherix to Hold Business Update Conference Call December 9, 2010 at 4:30 p.m. Eastern Time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2, 2015 Meet ARGUS, The ... Scan & Read People. Analyze emotions and predict actions. ... including the very first Responsive-RPG: "The Eye: Genesis". ... , , , , https://www.youtube.com/watch?v=B1ZEtAZ2Yf8 ... affect your inner feelings - and those of others. ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 “Stem Cell Therapy ... more mainstream, and it is used often as an adjunct ... general practitioners are not yet aware or comfortable enough with ... therapy is most often reserved for the last resort cases ... pet can barely lift a paw to get around. It ...
(Date:6/2/2015)... 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO ) ... leading provider of cord blood collection, laboratory testing, ... announced that the Special Committee of the Company,s board of ... ( China ) Limited as its independent financial ... its United States legal counsel and ...
(Date:6/2/2015)... 02, 2015 German-based Moenninghoff has designated ... distributor for the Moenninghoff product line . ... pleased to announce that the R.M. Hoffman Company will ... firm, founded in 1916, this is a strategically important ... the kind of professional distributor we need to successfully ...
Breaking Biology Technology:ARGUS - The World's First Inner Emotion Scanner Launches on KickStarter 2ARGUS - The World's First Inner Emotion Scanner Launches on KickStarter 3VetStem Biopharma, Proudly Announces a New Long Term Partnership with VCA West Los Angeles in Support of Stem Cell Therapy Training and Clinical Opportunities. 2VetStem Biopharma, Proudly Announces a New Long Term Partnership with VCA West Los Angeles in Support of Stem Cell Therapy Training and Clinical Opportunities. 3China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 2China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 3R.M. Hoffman Company designated official United States distributor for the Moenninghoff product line. 2R.M. Hoffman Company designated official United States distributor for the Moenninghoff product line. 3
... -- China Yingxia,International, Inc. (OTC Bulletin Board: ... provider in the nutraceutical industry engaged in ... food,products, supplements, and personal care products in ... it will conduct a conference call, on,Friday, ...
... HORSHAM, Pa., Aug. 8 Centocor, Inc., today ... has extended the review,timeline for the Biologic License ... months to December 2008. The,application, filed by Centocor ... the treatment of adult patients with chronic moderate ...
... Aug. 8 Carna Biosciences, Inc. ("Carna"),is pleased ... with,Caliper Life Sciences, Inc. USA ("Caliper") on August ... set of discrete protein kinases aiding,the expansion of ... Kinase Selectivity Assay Kits. Caliper,s products and,services are ...
Cached Biology Technology:China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results 2FDA Extends Review Timeline for Ustekinumab Biologic License Application Three Months 2Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences 2
(Date:5/27/2015)... CLEVELAND , May 27, 2015 /PRNewswire/ ... in medication safety systems and image documentation ... provider of comprehensive, technologically-advanced automation solutions, is ... art integration. The Codonics® Safe Label System® ... used in conjunction with the Omnicell Anesthesia ...
(Date:5/25/2015)... 25, 2015  Australia,s market for wearable technologies is ... saw the advent of several trials and prototypes. The ... is expected to ignite interest in wearables as well ... Australia . This in turn will spur greater ... new partnerships amongst vendors and distributors. ...
(Date:5/22/2015)... , May 22, 2015 According ... by Solution (2D, 3D, Thermal, Emotion, Forensic), by Software (Middleware, ... (Government and Utilities, Consumer and Home) - Global Forecast ... grow from $2.77 Billion in 2015 to $6.19 Billion ... Browse 79 market data Tables and   43 ...
Breaking Biology News(10 mins):Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3
... American Chemical Society (ACS) News Service Weekly press package ... and Chemical & Engineering News. With more than 160,000 ... cite the individual journal, or the American Chemical Society, ... ARTICLE #1 FOR IMMEDIATE RELEASE Vaccine-like ...
... the October 1 issue of G&D, Dr. Guillermo ... colleagues present new evidence to resolve a century-old ... vasculature. Understanding the development of the lymphatic vasculature ... health (mediating immunity and maintaining tissue fluid levels) ...
... presents research on the genetic make-up and biology of ... better diagnosis and treatment of the diarrhea disease giardiasis, ... may also bring an understanding of several vital biological ... parasite that exists all over the world and causes ...
Cached Biology News:American Chemical Society's Weekly PressPac -- Sept. 26, 2007 2American Chemical Society's Weekly PressPac -- Sept. 26, 2007 3American Chemical Society's Weekly PressPac -- Sept. 26, 2007 4American Chemical Society's Weekly PressPac -- Sept. 26, 2007 5American Chemical Society's Weekly PressPac -- Sept. 26, 2007 6American Chemical Society's Weekly PressPac -- Sept. 26, 2007 7American Chemical Society's Weekly PressPac -- Sept. 26, 2007 8New Swedish research hope for millions of sufferers 2
...
AgarPlaque Plus Agarose 50 grams...
DL-Dithiothreitol (Clelands Reagent) ,PROTEASE FREE!! ,Molecular Biology Grade ,PRODUCT MUST SHIP NEXT DAY DURING HOT SUMMER MONTHS. ,C 4 H 10 O 2 S 2 ,Molecular Weight: 154.25 ,CAS RN: [27565-...
BD IMag Anti-Mouse CD90.2 (Thy1.2) Particles-DM 2 x 109 cells...
Biology Products: